Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-29

FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Lumify Redness Reliever Eye Drops (brimonidine tartrate) by Bausch & Lomb, expanding labeling to include relief of o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMIFY REDNESS RELIEVER EYE DROPS (Brimonidine tartrate)

Snippet

SUPPL AP for LUMIFY REDNESS RELIEVER EYE DROPS (BRIMONIDINE TARTRATE)